<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta charset="utf-8"><meta http-equiv="X-UA-Compatible" content="IE=edge"><meta name="viewport" content="width=device-width, initial-scale=1.0"><!-- Inform modern browsers that this page supports both dark and light color schemes,
  and the page author prefers light. --><meta name="color-scheme" content="dark light"><script>
  // If `prefers-color-scheme` is not supported, fall back to light mode.
  // i.e. In this case, inject the `light` CSS before the others, with
  // no media filter so that it will be downloaded with highest priority.
  if (window.matchMedia("(prefers-color-scheme: dark)").media === "not all") {
    document.documentElement.style.display = "none";
    document.head.insertAdjacentHTML(
      "beforeend",
      "<link id=\"css\" rel=\"stylesheet\" href=\"https://bootswatch.com/3/flatly/bootstrap.css\" onload=\"document.documentElement.style.display = ''\">"
    );
  }
</script><title>Studies on Antidepressants for the Primary Care Setting — dat.linde2016 • metadat</title><!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script><!-- Bootstrap --><script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css"><script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous"><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous"><!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet"><script src="../pkgdown.js"></script><meta property="og:title" content="Studies on Antidepressants for the Primary Care Setting — dat.linde2016"><meta property="og:description" content="Results from 93 trials examining 22 interventions (including placebo and usual care) for the primary care of depression."><meta name="twitter:card" content="summary_large_image"><meta name="twitter:creator" content="@wviechtb"><meta name="twitter:site" content="@wviechtb"><!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]--><!-- Flatly Theme - Light  --><link id="css-light" rel="stylesheet" href="https://bootswatch.com/3/flatly/bootstrap.css" media="(prefers-color-scheme: light), (prefers-color-scheme: no-preference)"><!-- Darkly Theme - Dark --><link id="css-dark" rel="stylesheet" href="https://bootswatch.com/3/darkly/bootstrap.css" media="(prefers-color-scheme: dark)"><!-- preferably CSS --><link rel="stylesheet" href="../preferably.css"><link id="css-code-light" rel="stylesheet" href="../code-color-scheme-light.css" media="(prefers-color-scheme: light), (prefers-color-scheme: no-preference)"><link id="css-code-dark" rel="stylesheet" href="../code-color-scheme-dark.css" media="(prefers-color-scheme: dark)"><script src="../darkswitch.js"></script></head><body data-spy="scroll" data-target="#toc">
    

    <div class="container template-reference-topic">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">metadat</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">1.1-0</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav"><li>
  <a href="../index.html">
    <span class="fa fa-home fa-lg"></span>
     
  </a>
</li>
<li>
  <a href="../reference/index.html">Datasets / Functions</a>
</li>
<li>
  <a href="../news/index.html">Changelog</a>
</li>
      </ul><ul class="nav navbar-nav navbar-right"><li>
          <a href="#" id="css-toggle-btn">
            <span class="fas fa-adjust fa-lg"></span>
          </a>
        </li>
        
        <li>
  <a href="https://twitter.com/wviechtb" class="external-link">
    <span class="fa fa-twitter"></span>
     
  </a>
</li>
<li>
  <a href="https://github.com/wviechtb/metadat" class="external-link">
    <span class="fa fa-github"></span>
     
  </a>
</li>
        
        


      </ul></div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

      

      </header><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header">
    <h1>Studies on Antidepressants for the Primary Care Setting</h1>
    
    <div class="hidden name"><code>dat.linde2016.Rd</code></div>
    </div>

    <div class="ref-description">
    <p>Results from 93 trials examining 22 interventions (including placebo and usual care) for the primary care of depression.</p>
    </div>

    <div id="ref-usage">
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="va">dat.linde2016</span></code></pre></div>
    </div>

    <div id="format">
    <h2>Format</h2>
    <p>The data frame contains the following columns:</p><table class="table table"><tr><td><b>id</b></td><td><code>integer</code></td><td>study ID</td></tr><tr><td><b>lnOR</b></td><td><code>numeric</code></td><td>response after treatment (log odds ratio)</td></tr><tr><td><b>selnOR</b></td><td><code>numeric</code></td><td>standard error of log odds ratio</td></tr><tr><td><b>treat1</b></td><td><code>character</code></td><td>first treatment</td></tr><tr><td><b>treat2</b></td><td><code>character</code></td><td>second treatment</td></tr></table></div>
    <div id="details">
    <h2>Details</h2>
    <p>This data set comes from a network meta-analysis of 22 treatments of depression in primary care (Linde et al., 2016), based on 93 trials (79 two-arm trials, 13 three-arm trials, and one four-arm trial). The primary outcome was response after treatment (yes/no), defined as a reduction from baseline by at least 50% on a depression scale. The data set contains log odds ratios with standard errors for all pairwise comparisons.</p>
<p>The interventions comprised both medical and psychological treatments, also in combination, including placebo and usual care (UC) (Linde et al., 2016). Pharmacological interventions were tricyclic antidepressants (TCA), selective serotonin reuptake inhibitors (SSRI), serotonin-noradrenaline reuptake inhibitors (SNRI), noradrenaline reuptake inhibitors (NRI), low- dose serotonin (5-HT2) antagonists and reuptake inhibitors (low-dose SARI), noradrenergic and specific serotonergic agents (NaSSa), reversible inhibitors of monoaminoxidase A (rMAO-A), hypericum extracts, and an individualized drug. Psychological interventions were cognitive behavioral therapy (CBT; four forms: face-to-face CBT, remote therapist-led CBT, guided self-help CBT, and no or minimal contact CBT), face-to-face problem-solving therapy (PST), face-to-face interpersonal psychotherapy, face-to-face psychodynamic therapy, and “other face-to-face therapy”. Combination therapies were face-to-face CBT + SSRI, face-to-face PST + SSRI, and face-to-face interpersonal psychotherapy + SSRI.</p>
<p>The data set was used as an example in Rücker et al. (2020) to illustrate component network meta-analysis using frequentist methods.</p>
    </div>
    <div id="source">
    <h2>Source</h2>
    <p>Linde, K., Rücker, G., Schneider, A., &amp; Kriston, L. (2016). Questionable assumptions hampered interpretation of a network meta-analysis of primary care depression treatments. <em>Journal of Clinical Epidemiology</em>, <b>71</b>, 86–96. <a href="https://doi.org/10.1016/j.jclinepi.2015.10.010" class="external-link">https://doi.org/10.1016/j.jclinepi.2015.10.010</a></p>
    </div>
    <div id="references">
    <h2>References</h2>
    <p>Rücker, G., Petropoulou, M., &amp; Schwarzer, G. (2020). Network meta-analysis of multicomponent interventions. <em>Biometrical Journal</em>, <b>62</b>(3), 808–821. <a href="https://doi.org/10.1002/bimj.201800167" class="external-link">https://doi.org/10.1002/bimj.201800167</a></p>
    </div>
    <div id="author">
    <h2>Author</h2>
    <p>Guido Schwarzer, <a href="mailto:sc@imbi.uni-freiburg.de">sc@imbi.uni-freiburg.de</a>, <a href="https://github.com/guido-s/" class="external-link">https://github.com/guido-s/</a></p>
    </div>
    <div id="see-also">
    <h2>See also</h2>
    <div class="dont-index"><p><code><a href="https://rdrr.io/pkg/netmeta/man/netmeta.html" class="external-link">netmeta</a></code></p></div>
    </div>

    <div id="ref-examples">
    <h2>Examples</h2>
    <div class="sourceCode"><pre class="sourceCode r"><code><span class="r-in"><span class="co">### Show results of first three studies (first study has three treatment</span></span>
<span class="r-in"><span class="co">### arms)</span></span>
<span class="r-in"><span class="fu"><a href="https://rdrr.io/r/utils/head.html" class="external-link">head</a></span><span class="op">(</span><span class="va">dat.linde2016</span>, <span class="fl">5</span><span class="op">)</span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span>   id      lnOR   selnOR treat1  treat2</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 1  1 -0.570249 0.362066    TCA    SNRI</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 2  1  0.094727 0.339731    TCA Placebo</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 3  1  0.664976 0.358845   SNRI Placebo</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 4  4  0.916291 0.555278    TCA Placebo</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> 5  7  0.459532 0.510847    TCA Placebo</span>
<span class="r-in"></span>
<span class="r-in"><span class="co"># \dontrun{</span></span>
<span class="r-in"></span>
<span class="r-in"><span class="co">### Load netmeta package</span></span>
<span class="r-in"><span class="fu"><a href="https://rdrr.io/r/base/message.html" class="external-link">suppressPackageStartupMessages</a></span><span class="op">(</span><span class="kw"><a href="https://rdrr.io/r/base/library.html" class="external-link">library</a></span><span class="op">(</span><span class="va"><a href="https://github.com/guido-s/netmeta" class="external-link">netmeta</a></span><span class="op">)</span><span class="op">)</span></span>
<span class="r-in"></span>
<span class="r-in"><span class="co">### Print odds ratios and confidence limits with two digits</span></span>
<span class="r-in"><span class="fu"><a href="https://rdrr.io/pkg/meta/man/settings.meta.html" class="external-link">settings.meta</a></span><span class="op">(</span>digits <span class="op">=</span> <span class="fl">2</span><span class="op">)</span></span>
<span class="r-in"></span>
<span class="r-in"><span class="co">### Define order of treatments in printouts and forest plots</span></span>
<span class="r-in"><span class="va">trts</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="st">"SSRI"</span>,</span>
<span class="r-in">  <span class="st">"Face-to-face CBT"</span>, <span class="st">"Face-to-face interpsy"</span>, <span class="st">"Face-to-face PST"</span>,</span>
<span class="r-in">  <span class="st">"Face-to-face CBT + SSRI"</span>, <span class="st">"Face-to-face interpsy + SSRI"</span>,</span>
<span class="r-in">  <span class="st">"Face-to-face PST + SSRI"</span>,</span>
<span class="r-in">  <span class="st">"Face-to-face psychodyn"</span>, <span class="st">"Other face-to-face"</span>,</span>
<span class="r-in">  <span class="st">"TCA"</span>, <span class="st">"SNRI"</span>, <span class="st">"NRI"</span>, <span class="st">"Low-dose SARI"</span>, <span class="st">"NaSSa"</span>, <span class="st">"rMAO-A"</span>, <span class="st">"Ind drug"</span>,</span>
<span class="r-in">  <span class="st">"Hypericum"</span>,</span>
<span class="r-in">  <span class="st">"Remote CBT"</span>, <span class="st">"Self-help CBT"</span>, <span class="st">"No contact CBT"</span>,</span>
<span class="r-in">  <span class="st">"UC"</span>, <span class="st">"Placebo"</span><span class="op">)</span></span>
<span class="r-in"></span>
<span class="r-in"><span class="co">### Conduct random effects network meta-analysis</span></span>
<span class="r-in"><span class="va">net</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/netmeta/man/netmeta.html" class="external-link">netmeta</a></span><span class="op">(</span><span class="va">lnOR</span>, <span class="va">selnOR</span>, <span class="va">treat1</span>, <span class="va">treat2</span>, <span class="va">id</span>,</span>
<span class="r-in">  data <span class="op">=</span> <span class="va">dat.linde2016</span>, reference.group <span class="op">=</span> <span class="st">"placebo"</span>,</span>
<span class="r-in">  seq <span class="op">=</span> <span class="va">trts</span>, sm <span class="op">=</span> <span class="st">"OR"</span>, fixed <span class="op">=</span> <span class="cn">FALSE</span><span class="op">)</span></span>
<span class="r-in"></span>
<span class="r-in"><span class="co">### Network graph</span></span>
<span class="r-in"><span class="fu"><a href="https://rdrr.io/pkg/netmeta/man/netgraph.html" class="external-link">netgraph</a></span><span class="op">(</span><span class="va">net</span>, seq <span class="op">=</span> <span class="st">"o"</span>, number <span class="op">=</span> <span class="cn">TRUE</span><span class="op">)</span></span>
<span class="r-plt img"><img src="dat.linde2016-1.png" alt="" width="864" height="768"></span>
<span class="r-in"></span>
<span class="r-in"><span class="co">### Show results</span></span>
<span class="r-in"><span class="va">net</span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of studies: k = 93</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of pairwise comparisons: m = 124</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of treatments: n = 22</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of designs: d = 40</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Random effects model</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Treatment estimate (sm = 'OR', comparison: other treatments vs 'Placebo'):</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                 OR        95%-CI    z  p-value</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> SSRI                          1.71 (1.46-  2.01) 6.61 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face CBT              2.05 (1.26-  3.36) 2.86   0.0042</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face interpsy         1.11 (0.76-  1.62) 0.54   0.5897</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face PST              1.39 (0.97-  2.00) 1.77   0.0770</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face CBT + SSRI      30.86 (4.94-192.81) 3.67   0.0002</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face interpsy + SSRI  1.75 (1.12-  2.74) 2.47   0.0135</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face PST + SSRI       1.54 (0.66-  3.59) 1.01   0.3136</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face psychodyn        1.54 (0.48-  5.00) 0.72   0.4700</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Other face-to-face            1.91 (1.18-  3.12) 2.62   0.0089</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> TCA                           1.75 (1.47-  2.07) 6.40 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> SNRI                          1.93 (1.49-  2.49) 5.04 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> NRI                           1.45 (0.92-  2.27) 1.61   0.1066</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Low-dose SARI                 1.84 (1.25-  2.69) 3.10   0.0019</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> NaSSa                         1.22 (0.89-  1.66) 1.25   0.2103</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> rMAO-A                        1.08 (0.73-  1.59) 0.36   0.7158</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Ind drug                      2.54 (0.96-  6.76) 1.87   0.0613</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Hypericum                     2.00 (1.62-  2.47) 6.48 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Remote CBT                    2.14 (1.29-  3.54) 2.94   0.0033</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Self-help CBT                 1.94 (1.13-  3.32) 2.42   0.0156</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> No contact CBT                1.77 (1.01-  3.07) 2.01   0.0446</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> UC                            1.16 (0.76-  1.76) 0.69   0.4882</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Placebo                          .             .    .        .</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Quantifying heterogeneity / inconsistency:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> tau^2 = 0.0174; tau = 0.1319; I^2 = 15.1% (0.0%-35.6%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Tests of heterogeneity (within designs) and inconsistency (between designs):</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                      Q d.f. p-value</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Total           102.45   87  0.1234</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Within designs   58.07   54  0.3279</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Between designs  44.38   33  0.0892</span>
<span class="r-in"><span class="fu"><a href="https://rdrr.io/pkg/meta/man/forest.meta.html" class="external-link">forest</a></span><span class="op">(</span><span class="va">net</span>, xlim <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">0.2</span>, <span class="fl">50</span><span class="op">)</span><span class="op">)</span></span>
<span class="r-plt img"><img src="dat.linde2016-2.png" alt="" width="864" height="768"></span>
<span class="r-in"></span>
<span class="r-in"><span class="co">### Additive component network meta-analysis with placebo as inactive</span></span>
<span class="r-in"><span class="co">### treatment</span></span>
<span class="r-in"><span class="va">nc</span> <span class="op">&lt;-</span> <span class="fu"><a href="https://rdrr.io/pkg/netmeta/man/netcomb.html" class="external-link">netcomb</a></span><span class="op">(</span><span class="va">net</span>, inactive <span class="op">=</span> <span class="st">"placebo"</span><span class="op">)</span></span>
<span class="r-in"><span class="va">nc</span></span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of studies: k = 93</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of pairwise comparisons: m = 124</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of treatments: n = 22</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of active components: c = 18</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Number of designs: d = 40</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Results for combinations (additive model, random effects model):</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                                OR      95%-CI    z  p-value</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> SSRI                         1.69 (1.45-1.97) 6.81 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face CBT             2.31 (1.44-3.70) 3.48   0.0005</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face interpsy        1.10 (0.79-1.54) 0.57   0.5693</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face PST             1.37 (0.96-1.96) 1.72   0.0856</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face CBT + SSRI      3.91 (2.32-6.59) 5.12 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face interpsy + SSRI 1.86 (1.25-2.78) 3.05   0.0023</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face PST + SSRI      2.32 (1.52-3.53) 3.91 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face psychodyn       1.52 (0.47-4.96) 0.70   0.4853</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Other face-to-face           2.08 (1.29-3.33) 3.02   0.0025</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> TCA                          1.74 (1.47-2.05) 6.53 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> SNRI                         1.90 (1.47-2.46) 4.91 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> NRI                          1.43 (0.90-2.26) 1.52   0.1291</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Low-dose SARI                1.83 (1.24-2.69) 3.05   0.0023</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> NaSSa                        1.21 (0.88-1.65) 1.18   0.2371</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> rMAO-A                       1.07 (0.72-1.59) 0.33   0.7399</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Ind drug                     2.76 (1.04-7.33) 2.03   0.0420</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Hypericum                    1.99 (1.61-2.46) 6.41 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Remote CBT                   2.33 (1.42-3.81) 3.36   0.0008</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Self-help CBT                2.08 (1.23-3.53) 2.72   0.0064</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> No contact CBT               1.89 (1.10-3.27) 2.29   0.0219</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> UC                           1.24 (0.83-1.85) 1.07   0.2862</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Placebo                      1.00 (1.00-1.00)   --       --</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Results for components (random effects model):</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                          OR      95%-CI    z  p-value</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face CBT       2.31 (1.44-3.70) 3.48   0.0005</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face PST       1.37 (0.96-1.96) 1.72   0.0856</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face interpsy  1.10 (0.79-1.54) 0.57   0.5693</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Face-to-face psychodyn 1.52 (0.47-4.96) 0.70   0.4853</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Hypericum              1.99 (1.61-2.46) 6.41 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Ind drug               2.76 (1.04-7.33) 2.03   0.0420</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Low-dose SARI          1.83 (1.24-2.69) 3.05   0.0023</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> NRI                    1.43 (0.90-2.26) 1.52   0.1291</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> NaSSa                  1.21 (0.88-1.65) 1.18   0.2371</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> No contact CBT         1.89 (1.10-3.27) 2.29   0.0219</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Other face-to-face     2.08 (1.29-3.33) 3.02   0.0025</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Remote CBT             2.33 (1.42-3.81) 3.36   0.0008</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> SNRI                   1.90 (1.47-2.46) 4.91 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> SSRI                   1.69 (1.45-1.97) 6.81 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Self-help CBT          2.08 (1.23-3.53) 2.72   0.0064</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> TCA                    1.74 (1.47-2.05) 6.53 &lt; 0.0001</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> UC                     1.24 (0.83-1.85) 1.07   0.2862</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> rMAO-A                 1.07 (0.72-1.59) 0.33   0.7399</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Quantifying heterogeneity / inconsistency:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> tau^2 = 0.0208; tau = 0.1441; I^2 = 17.5% (0.0%-37.1%)</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> </span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Heterogeneity statistics:</span>
<span class="r-out co"><span class="r-pr">#&gt;</span>                     Q df p-value</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Additive model 109.12 90  0.0832</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Standard model 102.45 87  0.1234</span>
<span class="r-out co"><span class="r-pr">#&gt;</span> Difference       6.67  3  0.0831</span>
<span class="r-in"><span class="fu"><a href="https://rdrr.io/pkg/meta/man/forest.meta.html" class="external-link">forest</a></span><span class="op">(</span><span class="va">nc</span>, xlim <span class="op">=</span> <span class="fu"><a href="https://rdrr.io/r/base/c.html" class="external-link">c</a></span><span class="op">(</span><span class="fl">0.2</span>, <span class="fl">50</span><span class="op">)</span><span class="op">)</span></span>
<span class="r-plt img"><img src="dat.linde2016-3.png" alt="" width="864" height="768"></span>
<span class="r-in"></span>
<span class="r-in"><span class="co"># }</span></span>
</code></pre></div>
    </div>
  </div>
  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">
    <nav id="toc" data-toggle="toc" class="sticky-top"><h2 data-toc-skip>Contents</h2>
    </nav></div>
</div>


      <footer><div class="copyright">
  <p></p><p>Developed by Thomas White, Daniel Noble, Alistair Senior, W. Kyle Hamilton, Wolfgang Viechtbauer.</p>
</div>

<div class="pkgdown">
  <p></p><p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.1.</p>
  <p class="preferably">Using <a href="https://preferably.amirmasoudabdol.name/?source=footer" class="external-link">preferably</a> template.</p>
</div>

      </footer></div>

  


  

  </body></html>

